ResMed Inc. (NYSE:RMD) is looking for tuck-in acquisitions. Brett Sandercock, Chief Financial Officer said, "Going forward, we plan to continue to reinvest in growth through R&D and also expect to continue to deploy capital for tuck-in acquisitions, such as the recently announced acquisition of mementor, a German pioneer and health tech start-up that develops and distributes digital medical products in the field of sleep medicine and related areas".
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
215.8 USD | -0.54% | -0.64% | +25.45% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.45% | 31.88B | |
+8.27% | 218B | |
+6.93% | 184B | |
+13.13% | 135B | |
-0.27% | 62.38B | |
+11.57% | 51.37B | |
+7.76% | 50.9B | |
+1.24% | 40.87B | |
+2.88% | 36.28B | |
+17.81% | 24.39B |
- Stock Market
- Equities
- RMD Stock
- News ResMed, Inc.
- ResMed Seeks Tuck-In Acquisitions